Skip to content

Opaleye Management Inc., 10% owner at Grace Therapeutics, bought GRCE on Oct 16, 2026

Data as of Oct 16

▲ BUY$68.8K36,347 shares at $1.89Opaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.
Watch GRCE
Traded
Oct 16, 2026
Disclosed
Oct 16, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Opaleye Management Inc., 10% owner at Grace Therapeutics, bought GRCE on Oct 16, 2026TRADEDDISCLOSED
GRCESimilar stocks (XLV — its sector index fund), rebased to GRCE's price on the disclosure day
GRCE since disclosure
0.0%
Similar stocks (XLV) since disclosure
0.0%
XLV — its sector index fund

Change in closing price from Oct 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$45.7Kdisclosed Oct 16 · filed 1 day after the trade
  2. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$21.7Kdisclosed Oct 16 · filed 2 days after the trade

See every trade on GRCE →